Connexin 31.1 activators belong to a specific category of chemical compounds that play a pivotal role in modulating the function of connexin proteins, specifically connexin 31.1 (Cx31.1). Connexins are a family of transmembrane proteins that form gap junctions, which are channels that facilitate direct cell-to-cell communication in various tissues and organs. Cx31.1 is one member of this family, found predominantly in the skin and certain other tissues. Gap junctions formed by Cx31.1 are crucial for the exchange of ions, metabolites, and signaling molecules between adjacent cells, thereby coordinating various physiological processes. Connexin 31.1 activators are small molecules or compounds designed to enhance the opening or function of Cx31.1 gap junctions, ultimately promoting intercellular communication within specific tissues where this connexin is expressed.
These activators typically work by binding to Cx31.1 proteins or influencing their conformation, leading to an increased permeability of the gap junctions formed by these proteins. This enhanced intercellular communication can have important implications for tissue homeostasis and cellular function, as it enables synchronized responses among neighboring cells. While the specific mechanisms of action may vary among different connexin 31.1 activators, their common goal is to bolster the physiological functions of Cx31.1 in the tissues where it is expressed. These compounds have attracted research interest due to their ability in understanding the regulatory mechanisms of gap junctions and their role in various physiological processes, including skin development, wound healing, and possibly other functions where Cx31.1 is present. Further research is needed to uncover the full spectrum of effects and applications of connexin 31.1 activators, beyond their fundamental role in enhancing intercellular communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may activate Cx31.1 by influencing gene expression, potentially increasing the production of Cx31.1 protein or enhancing its incorporation into gap junctions. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $34.00 $64.00 $166.00 $281.00 | 4 | |
Linoleic acid can activate Cx31.1 by altering the lipid composition of the cell membrane, which affects the physical properties of gap junction channels. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic acid can activate Cx31.1 similarly to linoleic acid, by modifying membrane lipids and affecting the channel's gating properties. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid may activate Cx31.1 by influencing the fluidity and permeability of the cell membrane, potentially facilitating channel opening. | ||||||
Palmitoleic acid | 373-49-9 | sc-205424 sc-205424A sc-205424B sc-205424C sc-205424D | 100 mg 500 mg 1 g 5 g 10 g | $33.00 $135.00 $238.00 $1039.00 $1907.00 | 4 | |
Palmitoleic acid, like other fatty acids, can modify the lipid environment around Cx31.1, potentially promoting its channel activity. | ||||||
Carbenoxolone | 5697-56-3 | sc-507294 | 1 g | $50.00 | ||
Carbenoxolone is thought to activate Cx31.1 by blocking gap junction channels' voltage-dependent closure, thereby allowing for increased intercellular communication. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid may activate Cx31.1 by modifying the biophysical properties of the gap junction channel, potentially enhancing its conductance. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $27.00 $79.00 $154.00 $309.00 | 1 | |
Flufenamic acid, like niflumic acid, may influence the channel's biophysical properties and activate Cx31.1 by increasing its conductance. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Probenecid is believed to activate Cx31.1 by inhibiting gap junction channel closure and enhancing the exchange of ions and small molecules between connected cells. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Quinine is an alkaloid that may activate Cx31.1 by modifying the electrochemical properties of the channel, potentially increasing its permeability to ions. | ||||||